Treatment of MFH(Malignant fibrous histiocytoma) in Extremity

사지에 발생한 악성섬유조직구종의 치료 경험

  • Kang, Jong Hwa (Institute for Human Tissue Restoration, Department of Plastic & Reconstructive Surgery, Yonsei University College of Medicine) ;
  • Lee, Won Jai (Institute for Human Tissue Restoration, Department of Plastic & Reconstructive Surgery, Yonsei University College of Medicine) ;
  • Lew, Dae Hyun (Institute for Human Tissue Restoration, Department of Plastic & Reconstructive Surgery, Yonsei University College of Medicine) ;
  • Rah, Dong Kyun (Institute for Human Tissue Restoration, Department of Plastic & Reconstructive Surgery, Yonsei University College of Medicine) ;
  • Tark, Kwan Chul (Institute for Human Tissue Restoration, Department of Plastic & Reconstructive Surgery, Yonsei University College of Medicine)
  • 강종화 (연세대학교 의과대학 인체조직복원연구소, 성형외과학교실) ;
  • 이원재 (연세대학교 의과대학 인체조직복원연구소, 성형외과학교실) ;
  • 유대현 (연세대학교 의과대학 인체조직복원연구소, 성형외과학교실) ;
  • 나동균 (연세대학교 의과대학 인체조직복원연구소, 성형외과학교실) ;
  • 탁관철 (연세대학교 의과대학 인체조직복원연구소, 성형외과학교실)
  • Received : 2007.11.20
  • Accepted : 2008.04.25
  • Published : 2008.07.10

Abstract

Purpose: Malignant fibrous histiocytoma(MFH) is the most common soft tissue sarcoma in adult. As to this date, tissue development, treatment and prognosis of the tumor has not been definitely clarified, however, it has been reported that wide surgical resection of the tumor along with the radiotheraphy and chemotheraphy is needed for treatment. In MFH with high recurrence rate, the reconstruction method and points to be considered for reconstruction in recurrent case were studied in 10 patients who were treated in our hospital. Methods: From August of 1991 to August 2007, location of tumor, initial mass size, 1st recurred period, lymph node metastasis, recurrence rate, treatment modality, complication, reconstruction in recurrent defect, and follow up period was studied in 10 patients who underwent reconstruction at our Plastic surgery department following wide excision. Results: The average age was 62.8(46 - 73) years old, average follow up period was 7.7(1 - 17) years. Various reconstructions has been performed for recurrent cases and postoperative chemotheraphy and radiotheraphy was done. As for reconstruction in recurrent cases, After wide excision, local flap was performed in 6 cases, and free flap in 2 cases. After radiotherapy, osteoradionecrosis was occurred in 4 cases. Recurrence rate was 1 - 5(2.6) times and reconstruction due to recurrence was 7 out of 10 cases(70%). Conclusion: The treatment modality of MFH is not yet defined. Due to it's high recurrence rate, radiotherapy and chemotherapy is commonly combined with surgery. Even still, additional excision and reconstruction may be required. Therefore, possibility of re-operation must be considered when performing every excision and reconstruction; in case a recurrence or osteoradionecrosis occurs. Free flap coverage should be left as the last resort, according to the principle of reconstruction. Nevertheless, if the defect is large or osteoradionecrosis is present, it will benefit greatly to the patient's quality of life.

Keywords

References

  1. Ozzello L, Stout AP, Murray MR: Cultural characteristics of malignant histiocytomas and fibrous xanthomas. Cancer 16: 331, 1963 https://doi.org/10.1002/1097-0142(196303)16:3<331::AID-CNCR2820160307>3.0.CO;2-F
  2. Kempson RL, Kyriakos M: Fibroxanthosarcoma of the soft tissues. A type of malignant fibrous histiocytoma. Cancer 29: 961, 1972 https://doi.org/10.1002/1097-0142(197204)29:4<961::AID-CNCR2820290443>3.0.CO;2-A
  3. Enzinger FM, Weiss SW: Soft tissue tumors. 3rd ed. St Louis: CV Mosby, 1995, p 351
  4. O'Brien JE, Stout AP: Malignant fibrous xanthomas. Cancer 17: 1445, 1964 https://doi.org/10.1002/1097-0142(196411)17:11<1445::AID-CNCR2820171112>3.0.CO;2-G
  5. Elder D, Elenitsas R, Jaworsky C, Johnson B Jr: Leveros: Histopathology of the skin. 8th ed. Philadelphia: Lippincott-Raven, 1997, p 862
  6. Kauffman SL, Stout AP: Histiocytic tumors(fibrous xanthoma and histiocytoma) in children. Cancer 14: 469, 1961 https://doi.org/10.1002/1097-0142(199005/06)14:3<469::AID-CNCR2820140304>3.0.CO;2-Q
  7. Fu YS, Gabbiani G, Kaye GI, Lattes R: Malignant soft tissue tumors of probable histiocytic origin(malignant fibrous histiocytomas): general considerations and electron microscopic and tissue culture studies. Cancer 35: 176, 1975 https://doi.org/10.1002/1097-0142(197501)35:1<176::AID-CNCR2820350123>3.0.CO;2-N
  8. Hoffman MA, Dickersin GR: Malignant fibrous histiocytoma: an ultrastructural study of eleven cases. Hum Pathol 14: 913, 1983 https://doi.org/10.1016/S0046-8177(83)80166-X
  9. Weiss SW, Enzinger FM: Malignant fibrous histiocytoma: an analysis of 200 cases. Cancer 41: 2250, 1978 https://doi.org/10.1002/1097-0142(197806)41:6<2250::AID-CNCR2820410626>3.0.CO;2-W
  10. Erriksson M, Hardell L, Berg NO, Muller T, Axelson O: Soft tissue sarcomas and exposure to chemical substances: a case-referent study. Br J Ind Med 38: 27, 1981
  11. Buckley C, Thomas V, Crow J, Houlston R, Slack J, Rustin MH: Cancer family syndrome associated with multiple malignant melanomas and a malignant fibrous histiocytoma. Br J Dermatol 126: 83, 1992 https://doi.org/10.1111/j.1365-2133.1992.tb08410.x
  12. Salo JC, Lewis JJ, Woodruff JM, Leung DH, Brennan MF: Malignant fibrous histiocytoma of the extremity. Cancer 85: 1765, 1999 https://doi.org/10.1002/(SICI)1097-0142(19990415)85:8<1765::AID-CNCR17>3.0.CO;2-K